Determinants of progressive vascular calcification in haemodialysis patients (Q44854970)

6 December 2017

title

Determinants of progressive vascular calcification in haemodialysis patients (English)

1 reference

6 December 2017

main subject

vascular calcification

1 reference

1 reference

1

Glenn M Chertow

1 reference

6 December 2017

Paolo Raggi

2

1 reference

6 December 2017

Scott Chasan-Taber

3

1 reference

6 December 2017

Juergen Bommer

4

1 reference

6 December 2017

Herwig Holzer

5

1 reference

6 December 2017

Steven K Burke

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

21 April 2004

1 reference

Nephrology Dialysis Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

19

1 reference

6 December 2017

issue

6

1 reference

6 December 2017

page(s)

1489-1496

1 reference

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Pathophysiological mechanisms of vascular calcification in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Variability of repeated coronary artery calcium measurements by electron beam tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Quantification of coronary artery calcium using ultrafast computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: An electron-beam CT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Phosphate regulation of vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Arterial stiffening and vascular calcifications in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH125

21 January 2018

Identifiers

DOI

10.1093/NDT/GFH125

1 reference

6 December 2017

1 reference